Herbalife Ltd (HLF)
(Delayed Data from NYSE)
$8.16 USD
-0.32 (-3.77%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $8.19 +0.03 (0.37%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.16 USD
-0.32 (-3.77%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $8.19 +0.03 (0.37%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth C Momentum A VGM
Zacks News
Pharmacies & Drug Stores Industry Outlook: Prospects Look Weak
by Zacks Equity Research
Pharmacy retailers are gradually realizing the growing market demand for Medicare plan options. This apart, they are aggressively emphasizing on chronic disease care and management.
Will Volume Growth Continue Aiding Herbalife (HLF) in 2019?
by Zacks Equity Research
Herbalife (HLF) gains from continued rise in volume points and a strong global presence.
Zacks.com highlights: Herbalife Nutrition, Arch Coal, Crocs, Attunity and Cadence Design Systems
by Zacks Equity Research
Zacks.com highlights: Herbalife Nutrition, Arch Coal, Crocs, Attunity and Cadence Design Systems
Herbalife (HLF) Up 3.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Herbalife (HLF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Bet on These 5 Top-Ranked Liquid Stocks for Stellar Returns
by Zacks Equity Research
Here are five top-ranked liquid stocks that can make a winning portfolio for investors.
Zacks.com featured highlights include: Herbalife, Crocs, Attunity and Cadence Design
by Zacks Equity Research
Zacks.com featured highlights include: Herbalife, Crocs, Attunity and Cadence Design
4 Top-Ranked Liquid Stocks for Impressive Returns
by Zacks Equity Research
Here are four top-ranked liquid stocks that investors can count on for stellar returns.
US Stocks Enjoy Highest Post-Midterm Gains Since 1982: 5 Picks
by Swarup Gupta
A large swathe of market watchers thinks that a gridlocked Congress will be beneficial for U.S. equity markets.
The Zacks Analyst Blog Highlights: AVX, RH, Herbalife Nutrition, Lumentum Holdings and Methanex
by Zacks Equity Research
The Zacks Analyst Blog Highlights: AVX, RH, Herbalife Nutrition, Lumentum Holdings and Methanex
5 Best Stocks to Buy Ahead of Midterm Election
by Tirthankar Chakraborty
The S&P 500 has gained on average 15.3% in the six months following midterm election in the third year of a given presidency, which is incidentally this year.
New Strong Buy Stocks for November 1st
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
Herbalife (HLF) Q3 Earnings Top Estimates, Volumes Up Y/Y
by Zacks Equity Research
Volume point growth drives Herbalife's (HLF) top-line performance in Q3.
IPG Photonics' (IPGP) Q3 Earnings: Disappointment in Store?
by Zacks Equity Research
Increasing adoption of its high powered laser products is likely to support IPG Photonics' (IPGP) third-quarter results amid anticipated decline in Quasi CW Lasers sales.
ON Semiconductor's (ON) Q3 Earnings: What's in the Cards?
by Zacks Equity Research
ON Semiconductor's (ON) Q3 results are expected to benefit from strength in its automotive and industrial verticals. However, sluggish performance from communications end market remains a concern.
Akamai (AKAM) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Akamai's (AKAM) third-quarter results are expected to benefit from solid adoption of Kona Site Defender and Prolexic Solutions.
AppFolio (APPF) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
AppFolio's (APPF) third-quarter results are expected to benefit from higher property manager units and growing number of property manager customers.
Will Herbalife (HLF) Q3 Earnings Grow Amid Currency Hurdles?
by Zacks Equity Research
Herbalife (HLF) is likely to gain from efforts that support direct selling, solid volumes and seed-to-feed strategy. However, unfavorable currency movements are expected to play spoilsport.
Herbalife (HLF) Q3 Earnings Preview: What to Know Ahead of the Release
by Zacks Equity Research
Herbalife (HLF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include: Callaway Golf, Herbalife, IAC/InterActiveCorp, Inogen and Salesforce.com
by Zacks Equity Research
Zacks.com featured highlights include: Callaway Golf, Herbalife, IAC/InterActiveCorp, Inogen and Salesforce.com
Bet On 5 Stock Likely to Beat Earnings Estimates
by Sanghamitra Saha
These top-ranked stocks are likely to beat on bottom line in their next releases.
Zacks.com highlights: WillScot, Primerica, Bovie Medical, Shenandoah Telecommunications and Herbalife Nutrition
by Zacks Equity Research
Zacks.com highlights: WillScot, Primerica, Bovie Medical, Shenandoah Telecommunications and Herbalife Nutrition
Snap Up These 5 Stocks on New Analyst Coverage
by Zacks Equity Research
Increased analyst coverage over the last few weeks might translate into solid price appreciation for these stocks.
Direct Selling Strategy Helps Herbalife Rally 44% in a Year
by Zacks Equity Research
Herbalife (HLF) gains from focus on seed-to-feed strategy and solid investments to support direct selling. However, adverse currency movements weigh on its sales view.
Rite Aid (RAD) Posts In-Line Q2 Loss, Tops Sales, Alters Board
by Zacks Equity Research
Rite Aid's (RAD) second-quarter fiscal 2019 loss per share matches estimates while revenues beat. The company reshuffles its board and governance in response to the failed Albertsons merger.
4 Reasons Why You Should Buy Herbalife Post Q2 Earnings
by Zacks Equity Research
Herbalife (HLF) continues with its volume growth trend in the second quarter, which also marks the company's highest ever quarterly volume figure.